You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 29 Apr 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Monitoring sections

Updated
Apr 2026
Regimen
Published Date: 29 Apr 2026
Cancer Type:
Hematologic, 
Amyloidosis, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Monitoring sections

Updated
Apr 2026
Regimen
Published Date: 29 Apr 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Monitoring sections

Updated
Apr 2026
Regimen
Published Date: 29 Apr 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Monitoring sections

Updated
Apr 2026
Regimen
Published Date: 29 Apr 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:
Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Monitoring sections
Updated
Apr 2026
Regimen
Published Date: 29 Apr 2026
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Monitoring sections

Updated
Apr 2026
Drug

Published Date: 29 Apr 2026

Revision Summary:


Drug Monograph: Updated Adverse Effects, Dosing, and Monitoring sections
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)

Updated
Apr 2026
Drug

Published Date: 27 Apr 2026

Revision Summary:
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Updated
Apr 2026
Regimen
Published Date: 24 Apr 2026
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Intent section

Updated
Apr 2026
Regimen
Published Date: 23 Apr 2026
Cancer Type:
Gastrointestinal, 
Pancreas
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supportive Care, Adverse Effects, Drug Administration/Special Precautions, and Monitoring sections

Updated
Apr 2026
Drug

Published Date: 23 Apr 2026

Revision Summary:
Drug Monograph: Updated Mechanism of Action, Adverse Effects, Dosage with Toxicity, Administration, Special Precautions, Interactions, and Monitoring sections
Patient Info Sheet EN: Updated/revised information sheet
Updated
Apr 2026
Regimen
Published Date: 20 Apr 2026
Cancer Type:
Hematologic, 
Myelofibrosis
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2026

Pages